share_log

Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition

Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition

迷幻公司Core One Labs斥资300万美元新收购功能性蘑菇
Benzinga Real-time News ·  2021/12/27 13:06

Psychedelics company Core One Labs Inc. (CSE:COOL) (OTC:CLABF) is expanding into the functional mushroom space with the acquisition of New Path Laboratories Inc., a British Columbia-based company dedicated to the development and licensing of natural health products and dietary supplements.

迷幻药公司Core One Labs Inc.(CSE：COOL)(场外交易代码：CLABF)通过收购新路径实验室公司一家总部位于不列颠哥伦比亚省的公司，致力于天然保健品和膳食补充剂的开发和许可。

"This acquisition further extends the company's presence in the functional mushrooms space and also will allow the company to generate sales revenue by virtue of adding retail distribution channels to its business model and reach an exponentially growing consumer base," said Joel Shacker, CEO Core One Labs.

“此次收购进一步扩大了公司在功能性蘑菇领域的地位，还将使公司通过在其业务模式中增加零售分销渠道来创造销售收入，并接触到呈指数级增长的消费者基础，”他说。乔尔·谢克首席执行官Core One实验室。

New Path incorporates functional mushrooms to help support everyday biological functions in the maintenance of good health and has a vertical integration model that can allow it to grow, develop and distribute natural health products and dietary supplements from spore to sale. 

New Path结合了功能性蘑菇，以帮助支持维持健康的日常生物功能，并具有垂直整合模式，使其能够从孢子到销售种植、开发和分销天然保健品和膳食补充剂。

Core One has purchased New Path through an all-stock transaction of 5,700,000 common shares, valued at approximately CA$3.9 million ($3 million).

Core One通过570万股普通股的全股票交易收购了New Path，价值约390万加元(300万美元)。

Core One over-the-counter shares were $0.44 at the time of this writing.

在撰写本文时，Core One的场外股票为0.44美元。

Photo by Kalineri on Unsplash.

照片由卡莱尼在Unspash上拍摄。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发